Ultragenyx to Host Conference Call for First Quarter 2026 Financial Results and Corporate Update
Summary
NOVATO, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and com...
Description
NOVATO, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and com...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source